INLYTA
INLYTA
Approved
DIN Number
02389630
Drug Class
Human
Market Date
Aug 17, 2012
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02389630
AIG Number0153228001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01EK01 AXITINIB
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
AXITINIBActive
Strength: 1 MG
Monograph: AXITINIB